Herbal medicinal product Sinupret extract (BNO 1016) is safe and effective in the treatment of acute viral rhinosinusitis
- Authors: Jund R.1, Mondigler M.2, Stammer H.3, Stierna P.2, Bachert C.4
-
Affiliations:
- HNO-Praxis Puchheim
- Bionorica SE
- Pharmalog Institute for Clinical Research GmbH
- Ghent University Hospital
- Issue: Vol 24, No 3 (2022)
- Pages: 186-192
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/108066
- DOI: https://doi.org/10.26442/20751753.2022.3.201314
- ID: 108066
Cite item
Full Text
Abstract
Aim. The pooled efficacy data of two similar randomized placebo-controlled clinical trials were analyzed. Safety was evaluated on the basis of the individual trials.
Materials and methods. The efficacy analysis was based on 589 patients. Treatment was performed orally with either 3×160 mg BNO 1016 (n=294) or 3×1 tablet placebo (n=295) for 15 days. In both trials patients underwent five visits to the investigational sites. Symptoms were evaluated according to the EPOS 2012 guideline. Ultrasonography was used to confirm the diagnosis at onset of treatment and the remission of symptoms at the last visit. Efficacy was evaluated by the investigator as the mean major symptom score (MSS) at the end of treatment (visit 5, day 14). Patients reported symptoms and social/emotional consequences of rhinosinusitis using a quality of life questionnaire (SNOT-20 GAV).
Results. MSS improved during the treatment period by a mean of 10.02±1.61 score points to 2.47±2.55 for BNO 1016 and of 9.87±1.52 to 3.63±3.63 for placebo. Differences between treatment groups at end of therapy (1.16±3.14 score points; p<0.0001) and patient-assessed quality of life (p=0.0015) were statistically significant in favor of BNO 1016.
Conclusion. Daily intake of 480 mg of BNO 1016 for 15 days is an effective treatment in acute viral rhinosinusitis.
Full Text
##article.viewOnOriginalSite##About the authors
Rainer Jund
HNO-Praxis Puchheim
Email: Claus.Bachen@UGent.be
D. Sci. (Med.)
Germany, PuchheimMartin Mondigler
Bionorica SE
Email: Claus.Bachen@UGent.be
Germany, Neumarkt
Holger Stammer
Pharmalog Institute for Clinical Research GmbH
Email: Claus.Bachen@UGent.be
CEO, Head of Data Management/Biometrics Department
Germany, IsmaningPontus Stierna
Bionorica SE
Email: Claus.Bachen@UGent.be
D. Sci. (Med.)
Russian Federation, NeumarktClaus Bachert
Ghent University Hospital
Author for correspondence.
Email: Claus.Bachen@UGent.be
ORCID iD: 0000-0003-4742-1665
D. Sci. (Med.), Prof.
Belgium, GhentReferences
- Fokkens WJ, Lund VJ, Mullol J, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012;50(1):1-12. doi: 10.4193/Rhino12.000
- Masood A, Moumoulidis I, Panesar J. Acute rhinosinusitis in adults: an update on current management. Postgrad Med J. 2007;83(980):402-8. doi: 10.1136/pgmj.2006.054767
- Hellgren J, Cervin A, Nordling S, et al. Allergic rhinitis and the common cold – high costs to society. Allergy. 2010;65(6):776-83. doi: 10.1111/j.1398-9995.2009.02269.x
- Guo R, Canter PH, Ernst E. Herbal medicines for the treatment of rhinosinusitis: a systematic review. Otolaryngol Head Neck Surg. 2006;135(4):496-506. doi: 10.1016/j.otohns.2006.06.1254
- Reden J, El-Hifnawi D, Zahnert T, Hummel T. The effect of herbal combination of primrose, gentian root, vervain, elder flowers, and sorrel on olfactory function in patients with a sinonasal olfactory dysfunction. Rhinology. 2011;49(3):342-6. doi: 10.4193/Rhino10.151
- Ismail C. Pharmacology of Sinupret. Recent results on the rational for the Sinupret compound. HNO. 2005;53(Suppl. 1):S38-42. doi: 10.1007/s00106-005-1235-0
- Bachert C, Mondigler M, Steindl H, et al. Multicentre, randomised, double-blind, placebo-controlled, parallel-group dose-finding study of herbal medicine (dry extract) BNO 1016 in acute rhinosinu-sitis (ARhiSi-1). 84th Annual Meeting of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery, 2013.
- Jund R, Mondigler M, Steindl H, et al. Clinical efficacy of a dry extract of five herbal drugs in acute viral rhinosinusitis. Rhinology. 2012;50(4):417-26. doi: 10.4193/Rhino12.015
- Baumann I, Blumenstock G, De Maddalena H, et al. Quality of life in patients with chronic rhinosinusitis: validation of the Sino-Nasal Outcome Test-20 German Applied Version. HNO. 2007;55(1):42-7. doi: 10.1007/s00106-005-1347-6
- Bachert C, Schapowal A, Funk P, Kieser M. Treatment of acute rhinosinusitis with the preparation from Pelargonium sidoides EPs 7630: a randomized, double-blind, placebo-controlled trial. Rhinology. 2009;47(1):51-8.
- Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol. 2005;116(6):1289-95. doi: 10.1016/j.jaci.2005.08.044
- Revicki DA, Margolis MK, Thompson CL, et al. Major symptom score utility index for patients with acute rhinosinusitis. Am J Rhinol Allergy. 2011;25(3):99-106. doi: 10.2500/ajra.2011.25.3575
- Glatthar-Saalmüller B, Rauchhaus U, Rode S, et al. Antiviral activity of two preparations of the herbal medicinal product Sinupret™ against viruses causing respiratory infections. Phytomedicine. 2011;19(1):1-7. doi: 10.1016/j.phymed.2011.10.010
- Kreindler JL, Chen B, Kreitman Y, et al. The novel dry extract BNO 1011 stimulates chloride transport and ciliary beat frequency in human respiratory epithelial cultures. Am J Rhinol Allergy. 2012;26(6):439-43. doi: 10.2500/ajra.2012.26.3821
- Meltzer J, Saller R, Schapowal A, Brignoli R. Systematic review of clinical data with BNO-101 (Sinupret) in the treatment of sinusitis. Forsch Komplementmed. 2006;13(2):78-87. doi: 10.1159/000091969
- Rossi A, Dehm F, Kiesselbach C, et al. The novel Sinupret™ dry extracts exhibit anti-inflammatory effectiveness in vivo. Fitoterapia. 2012;83(4):715-20. doi: 10.1016/j.fitote.2012.02.008
- Lee JS, Kim IS, Kim JH, et al. Suppressive effects of Houttuynia cordata Thunb (Saururaceae) extract on Th2 immune response. J Ethnopharmacol. 2008;117(1):34-40. doi: 10.1016/j.jep.2008.01.013
- Zalmanovici Trestioreanu A, Yaphe J. Intranasal steroids for acute sinusitis. Cochrane Database Syst Rev. 2013;2013(12):CD005149. doi: 10.1002/14651858.CD005149.pub4